NEUN OTC
Neurogenesis, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -98.7%
5Y: -98.3%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$88K
+205.3% ▲
Total Liabilities
$193K
+5.8% ▲
Shareholders Equity
-$106K
+31.4% ▲
Cash & Investments
$14K
+1040.2% ▲
Total Debt
$147K
-5.1% ▼
Net Debt
$133K
-13.6% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2011 | FY2012 | FY2013 |
|---|---|---|---|
| — Assets — | |||
| Cash | $5K | $1K | $14K |
| Short-Term Investments | $0 | $0 | $0 |
| Cash & ST Investments | $5K | $1K | $14K |
| Net Receivables | $7K | $940 | $4K |
| Inventory | $31K | $5K | $48K |
| Other Current Assets | $8K | $0 | $4K |
| Total Current Assets | $51K | $12K | $71K |
| Property, Plant & Equip. | $4K | $4K | $4K |
| Goodwill & Intangibles | $10K | $13K | $13K |
| Long-Term Investments | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | $0 | $0 |
| Total Non-Current Assets | $14K | $17K | $17K |
| Total Assets | $66K | $29K | $88K |
| — Liabilities — | |||
| Accounts Payable | $14K | $3K | $19K |
| Short-Term Debt | $32K | $0 | $32K |
| Deferred Revenue | $0 | $0 | $0 |
| Other Current Liabilities | $28K | $16K | $28K |
| Total Current Liabilities | $75K | $19K | $78K |
| Long-Term Debt | $112K | $155K | $115K |
| Other Non-Current Liab. | $0 | $8K | $0 |
| Total Non-Current Liabilities | $112K | $164K | $115K |
| Total Liabilities | $187K | $183K | $193K |
| — Equity — | |||
| Common Stock | $709 | $709 | $709 |
| Retained Earnings | -$2M | -$2M | -$2M |
| Accumulated OCI | -$16K | $0 | $10K |
| Total Stockholders Equity | -$121K | -$154K | -$106K |
| Total Liabilities & Equity | $66K | $29K | $88K |
| — Key Metrics — | |||
| Total Debt | $144K | $155K | $147K |
| Net Debt | $139K | $154K | $133K |
| Total Investments | $0 | $0 | $0 |